The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

Researchers have long known that glycosaminoglycan-binding proteins (HBPs) help control vital processes like cell growth, ...

Boltz-2’s development was led by the Boltz team at MIT under the supervision of Professors Regina Barzilay and Tommi Jaakkola alongside a team of researchers from MIT and Recursion. For more ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

A new study in Small introduces a modular protein-DNA platform using covalent, site-specific links to create programmable ...

Researchers have developed an AI system capable of predicting whether and why proteins form sticky clumps, a process ...